HuGE Literature Finder
Records
1
-
4
Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2018 Apr . Hafizi Sina, Da Silva Tania, Meyer Jeffrey H, Kiang Michael, Houle Sylvain, Remington Gary, Prce Ivana, Wilson Alan A, Rusjan Pablo M, Sailasuta Napapon, Mizrahi Romi |
Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [F]FEPPA. The American journal of psychiatry 2016 Sep appiajp201616020171. Hafizi Sina, Tseng Huai-Hsuan, Rao Naren, Selvanathan Thiviya, Kenk Miran, Bazinet Richard P, Suridjan Ivonne, Wilson Alan A, Meyer Jeffrey H, Remington Gary, Houle Sylvain, Rusjan Pablo M, Mizrahi Romi |
Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes. Pharmacogenomics 2015 Jan 16 (1): 5-22. Pouget Jennie G, Gonçalves Vanessa F, Nurmi Erika L, P Laughlin Christopher, Mallya Karyn S, McCracken James T, Aman Michael G, McDougle Christopher J, Scahill Lawrence, Misener Virginia L, Tiwari Arun K, Zai Clement C, Brandl Eva J, Felsky Daniel, Leung Amy Q, Lieberman Jeffrey A, Meltzer Herbert Y, Potkin Steven G, Niedling Charlotte, Steimer Werner, Leucht Stefan, Knight Jo, Müller Daniel J, Kennedy James |
A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2013 Jan 33 (1): 53-8. Kreisl William C, Jenko Kimberly J, Hines Christina S, Lyoo Chul Hyoung, Corona Winston, Morse Cheryl L, Zoghbi Sami S, Hyde Thomas, Kleinman Joel E, Pike Victor W, McMahon Francis J, Innis Robert B, |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 25, 2022
- Content source: